SIGLEC7 and osteosarcoma: Our study elucidates a hitherto unobserved immune evasion mechanism in osteosarcoma, wherein GD2 engages SIGLECE in mice or SIGLEC7 in human on the surface of macrophage, triggering SHP2-mediated suppression of phagocytic activity.